PILL:NYE-Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF (USD)

ETF | Trading--Leveraged Equity |

Last Closing

USD 8.23

Change

+0.03 (+0.37)%

Market Cap

N/A

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-01 )

Largest Industry Peers for Trading--Leveraged Equity

Symbol Name Price(Change) Market Cap
SOXL Direxion Daily Semiconductor B..

-2.85 (-7.77%)

USD 12.27B
QLD ProShares Ultra QQQ

-2.85 (-2.83%)

USD 7.32B
FNGU MicroSectors FANG+ Index 3X Le..

-20.41 (-4.98%)

USD 5.28B
SSO ProShares Ultra S&P500

-1.68 (-1.86%)

USD 5.17B
UPRO ProShares UltraPro S&P500

-2.39 (-2.77%)

USD 4.05B
TECL Direxion Daily Technology Bull..

-6.28 (-7.17%)

USD 3.28B
USD ProShares Ultra Semiconductors

-8.18 (-6.82%)

USD 1.18B
YINN Direxion Daily FTSE China Bull..

+4.52 (+12.24%)

USD 1.15B
LABU Direxion Daily S&P Biotech Bul..

-3.49 (-2.71%)

USD 0.94B
DPST Direxion Daily Regional Banks ..

-9.72 (-9.77%)

USD 0.80B

ETFs Containing PILL

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Leveraged Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 6.19% 18% F 45% F
Dividend Return 1.00% 54% F 18% F
Total Return 7.20% 18% F 39% F
Trailing 12 Months  
Capital Gain 26.42% 17% F 66% D+
Dividend Return 1.78% 48% F 24% F
Total Return 28.20% 14% F 62% D
Trailing 5 Years  
Capital Gain -31.92% 28% F 14% F
Dividend Return 2.18% 34% F 6% D-
Total Return -29.74% 28% F 11% F
Average Annual (5 Year Horizon)  
Capital Gain -2.96% N/A N/A 23% F
Dividend Return -2.47% N/A N/A 14% F
Total Return 0.49% N/A N/A 12% F
Risk Return Profile  
Volatility (Standard Deviation) 105.69% N/A N/A 7% C-
Risk Adjusted Return -2.34% N/A N/A 23% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike